Tennessee Oncology Chattanooga — Chattanooga, Tennessee

Tennessee Oncology Chattanooga is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology Chattanooga has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Carcinoma, Pancreatic Ductal, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis.

Sponsors: Sumitomo Pharma America, Inc., Eli Lilly and Company, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology Chattanooga?

Tennessee Oncology Chattanooga has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology Chattanooga conducted?

Tennessee Oncology Chattanooga has 9 clinical trials on record, with 3 currently active. Their work covers Carcinoma, Pancreatic Ductal, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis.

Is Tennessee Oncology Chattanooga accredited by Crixeo Clinical Trials?

Tennessee Oncology Chattanooga has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology Chattanooga?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.